Impact of biliary complications on quality of life in live-donor liver transplant recipients.
Biliary complications
Cirrhosis
Live-donor liver transplantation
Mental health
Quality of life
The Short Form 12 version 2
Journal
World journal of hepatology
ISSN: 1948-5182
Titre abrégé: World J Hepatol
Pays: United States
ID NLM: 101532469
Informations de publication
Date de publication:
27 Oct 2021
27 Oct 2021
Historique:
received:
11
04
2021
revised:
23
06
2021
accepted:
23
09
2021
entrez:
17
11
2021
pubmed:
18
11
2021
medline:
18
11
2021
Statut:
ppublish
Résumé
Despite significant advancements in liver transplantation (LT) surgical procedures and perioperative care, post-LT biliary complications (BCs) remain a significant source of morbidity, mortality, and graft failure. In addition, data are conflicting regarding the health-related quality of life (HRQoL) of LT recipients. Thus, the success of LT should be considered in terms of both the survival and recovery of HRQoL. To assess the impact of BCs on the HRQoL of live-donor LT recipients (LDLT-Rs). We retrospectively analysed data for 25 LDLT-Rs who developed BCs post-LT between January 2011 and December 2016 at our institution. The Short Form 12 version 2 (SF 12v2) health survey was used to assess their HRQoL. We also included 25 LDLT-Rs without any post-LT complications as a control group. The scores for HRQoL of LDLT-Rs who developed BCs were significantly higher than the norm-based scores in the domains of physical functioning ( The development of BCs in LDLT-Rs causes a lower range of improvement in HRQoL.
Sections du résumé
BACKGROUND
BACKGROUND
Despite significant advancements in liver transplantation (LT) surgical procedures and perioperative care, post-LT biliary complications (BCs) remain a significant source of morbidity, mortality, and graft failure. In addition, data are conflicting regarding the health-related quality of life (HRQoL) of LT recipients. Thus, the success of LT should be considered in terms of both the survival and recovery of HRQoL.
AIM
OBJECTIVE
To assess the impact of BCs on the HRQoL of live-donor LT recipients (LDLT-Rs).
METHODS
METHODS
We retrospectively analysed data for 25 LDLT-Rs who developed BCs post-LT between January 2011 and December 2016 at our institution. The Short Form 12 version 2 (SF 12v2) health survey was used to assess their HRQoL. We also included 25 LDLT-Rs without any post-LT complications as a control group.
RESULTS
RESULTS
The scores for HRQoL of LDLT-Rs who developed BCs were significantly higher than the norm-based scores in the domains of physical functioning (
CONCLUSION
CONCLUSIONS
The development of BCs in LDLT-Rs causes a lower range of improvement in HRQoL.
Identifiants
pubmed: 34786175
doi: 10.4254/wjh.v13.i10.1405
pmc: PMC8568573
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1405-1416Informations de copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: All authors have nothing to disclose.
Références
World J Gastroenterol. 2014 May 14;20(18):5442-60
pubmed: 24833875
Clin Liver Dis. 2016 Feb;20(1):131-42
pubmed: 26593295
Liver Transpl. 2014 Jun;20(6):649-54
pubmed: 24678028
J Clin Sleep Med. 2014 Jan 15;10(1):21-6
pubmed: 24426816
Transpl Int. 2011 Jun;24(6):588-95
pubmed: 21382100
Liver Transpl. 2013 Nov;19 Suppl 2:S40-3
pubmed: 23960031
Transpl Int. 2019 Aug;32(8):792-793
pubmed: 30924559
Liver Transpl. 2019 Sep;25(9):1422-1438
pubmed: 31242345
Transplantation. 2019 Sep;103(9 Suppl 1):S1-S13
pubmed: 31449167
Int J Environ Res Public Health. 2020 May 27;17(11):
pubmed: 32471157
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Liver Transpl. 2020 May;26(5):702-708
pubmed: 32128971
Adv Ther. 2018 Nov;35(11):1729-1734
pubmed: 30328060
Psychosom Med. 2018 Feb/Mar;80(2):174-183
pubmed: 29112588
Br J Health Psychol. 2002 Nov;7(Part 4):393-408
pubmed: 12614493
World J Gastroenterol. 2012 Sep 28;18(36):5114-21
pubmed: 23049223
J Hepatol. 2016 Feb;64(2):433-485
pubmed: 26597456
Rev Esc Enferm USP. 2019 Mar 28;53:e03459
pubmed: 30942299
Transpl Int. 2019 Aug;32(8):808-819
pubmed: 30793373
Minerva Gastroenterol Dietol. 2018 Jun;64(2):180-186
pubmed: 29160655
Am J Transplant. 2018 Aug;18(8):1986-1994
pubmed: 29380529
Transplant Proc. 2018 Sep;50(7):2031-2038
pubmed: 30177104
J Gastrointestin Liver Dis. 2020 Oct 27;29(4):611-616
pubmed: 33118544
Transplant Proc. 2020 Mar;52(2):562-565
pubmed: 32057494
Palliat Med. 1995 Jul;9(3):207-19
pubmed: 7582177
Qual Life Res. 2019 Oct;28(10):2641-2650
pubmed: 31187410
World J Hepatol. 2016 Jun 28;8(18):749-56
pubmed: 27366301
Am J Phys Med Rehabil. 2017 Apr;96(4):273-288
pubmed: 27552351
Front Psychiatry. 2018 Apr 18;9:148
pubmed: 29720952
Liver Transpl. 2011 May;17(5):567-79
pubmed: 21506245
J Hepatol. 2016 Nov;65(5):929-937
pubmed: 27318325
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Metab Brain Dis. 2016 Aug;31(4):869-80
pubmed: 27032930
World J Gastroenterol. 2016 Jan 28;22(4):1593-606
pubmed: 26819525
Qual Life Res. 2020 Jun;29(6):1631-1639
pubmed: 32016682
J Psychosom Res. 2017 Apr;95:88-93
pubmed: 28185646
J Hepatol. 2009 Nov;51(5):949-59
pubmed: 19775771
Best Pract Res Clin Gastroenterol. 2020 Jun - Aug;46-47:101684
pubmed: 33158471
World J Gastroenterol. 2012 May 21;18(19):2295-9
pubmed: 22654420
J Hepatol. 2016 Dec;65(6):1232-1244
pubmed: 27515775
Cochrane Database Syst Rev. 2017 Mar 31;3:CD011639
pubmed: 28362060
Transplant Proc. 2016 Jan-Feb;48(1):132-7
pubmed: 26915858
Liver Int. 2014 Oct;34(9):1298-313
pubmed: 24703371
Clin Mol Hepatol. 2018 Dec;24(4):402-408
pubmed: 30300990
Aliment Pharmacol Ther. 2019 Mar;49(6):807-813
pubmed: 30714184
J Pain Symptom Manage. 2018 Jul;56(1):44-52
pubmed: 29526612